These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22087174)

  • 21. Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial.
    Look MP; Gerard A; Rao GS; Sudhop T; Fischer HP; Sauerbruch T; Spengler U
    Antiviral Res; 1999 Sep; 43(2):113-22. PubMed ID: 10517313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxyradical-mediated clastogenic plasma factors in psoriasis: increase in clastogenic activity after PUVA.
    Filipe P; Emerit I; Alaoui Youssefi A; Levy A; Cernjavski L; Freitas J; de Castro JL
    Photochem Photobiol; 1997 Oct; 66(4):497-501. PubMed ID: 9337621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent oxidative stress in patients with chronic active hepatitis-C infection after antiviral therapy failure.
    El-Kannishy G; Arafa M; Abdelaal I; Elarman M; El-Mahdy R
    Saudi J Gastroenterol; 2012; 18(6):375-9. PubMed ID: 23150023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
    Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.
    Vilar Gomez E; Gra Oramas B; Soler E; Llanio Navarro R; Ruenes Domech C
    Liver Int; 2007 Mar; 27(2):247-59. PubMed ID: 17311621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France.
    Pol S; Couzigou P; Bourlière M; Abergel A; Combis JM; Larrey D; Tran A; Moussalli J; Poupon R; Berthelot P; Bréchot C
    J Hepatol; 1999 Jul; 31(1):1-7. PubMed ID: 10424277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies.
    Fuchs J; Oelke N; Imhof M; Ochsendorf F; Schöfer H; Oromek G; Alaoui-Youssefi A; Emerit I
    Mol Med; 1998 May; 4(5):333-43. PubMed ID: 9642683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
    Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
    El-Zayadi AR; Attia M; Badran HM; El-Tawil A; Zalata K; Barakat E; Selim O; El-Nakeeb A; Saied A
    Liver Int; 2005 Aug; 25(4):746-51. PubMed ID: 15998425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress.
    Emerit I; Filipe P; Meunier P; Auclair C; Freitas J; Deroussent A; Gouyette A; Fernandes A
    Dermatology; 1997; 194(2):140-6. PubMed ID: 9094462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients.
    Kim YJ; Jang BK; Kim ES; Park KS; Cho KB; Chung WJ; Hwang JS
    Korean J Hepatol; 2012 Mar; 18(1):41-7. PubMed ID: 22511902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features.
    Serejo F; Emerit I; Filipe PM; Fernandes AC; Costa MA; Freitas JP; de Moura MC
    Can J Gastroenterol; 2003 Nov; 17(11):644-50. PubMed ID: 14631465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.
    Gurusamy KS; Tsochatzis E; Toon CD; Xirouchakis E; Burroughs AK; Davidson BR
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006803. PubMed ID: 24307460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
    Chemello L; Cavalletto L; Bernardinello E; Guido M; Pontisso P; Alberti A
    J Hepatol; 1995; 23 Suppl 2():8-12. PubMed ID: 8720287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial.
    Melhem A; Stern M; Shibolet O; Israeli E; Ackerman Z; Pappo O; Hemed N; Rowe M; Ohana H; Zabrecky G; Cohen R; Ilan Y
    J Clin Gastroenterol; 2005 Sep; 39(8):737-42. PubMed ID: 16082287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.